Intro

This chapter offers an in-depth look at the latest systemic therapy options for metastatic non-small cell lung cancer. It covers recommended chemotherapy regimens, the integration of immunotherapy, and the significance of PD-L1 status in shaping treatment decisions.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app